Angiotensin II, III, and IV may be important in the progression of COVID-19.
作者信息
Cure Erkan, Ilcol Tevfik Bulent, Cumhur Cure Medine
机构信息
Department of Internal Medicine, Ota & Jinemed Hospital, Istanbul, Turkey.
Department of Cardiology, Ota & Jinemed Hospital, Istanbul, Turkey.
出版信息
J Renin Angiotensin Aldosterone Syst. 2020 Oct-Dec;21(4):1470320320972019. doi: 10.1177/1470320320972019.
Abstract
摘要
相似文献
1
Angiotensin II, III, and IV may be important in the progression of COVID-19.血管紧张素II、III和IV可能在2019冠状病毒病的进展中起重要作用。
J Renin Angiotensin Aldosterone Syst. 2020 Oct-Dec;21(4):1470320320972019. doi: 10.1177/1470320320972019.
2
[Not Available].[无可用内容]。
Rev Med Suisse. 2020 Aug 5;16(701):1466-1467.
3
Biomarkers of biological age as predictors of COVID-19 disease severity.作为COVID-19疾病严重程度预测指标的生物学年龄生物标志物。
Aging (Albany NY). 2020 Apr 8;12(8):6490-6491. doi: 10.18632/aging.103052.
4
[2019 novel coronavirus, angiotensin converting enzyme 2 and cardiovascular drugs].[2019新型冠状病毒、血管紧张素转换酶2与心血管药物]
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Jul 24;48(7):532-538. doi: 10.3760/cma.j.cn112148-20200308-00171.
5
Postpartum exacerbation of antenatal COVID-19 pneumonia in 3 women.3例女性患者产前感染新冠病毒肺炎产后病情加重
CMAJ. 2020 Jun 1;192(22):E603-E606. doi: 10.1503/cmaj.200553. Epub 2020 May 6.
6
Could reperfusion pulmonary oedema explain worsening progress in COVID-19 pneumonia?再灌注性肺水肿能解释新冠病毒肺炎病情的恶化进展吗？
Emerg Med J. 2020 Nov;37(11):705-706. doi: 10.1136/emermed-2020-210085. Epub 2020 Sep 28.
7
Central involvement of SARS-CoV-2 may aggravate ARDS and hypertension.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的中枢神经系统受累可能会加重急性呼吸窘迫综合征（ARDS）和高血压。
J Renin Angiotensin Aldosterone Syst. 2020 Oct-Dec;21(4):1470320320972015. doi: 10.1177/1470320320972015.
8
[Angiotension converting enzyme 2 in the context of 2019 novel coronavirus infection：friend or foe？].2019新型冠状病毒感染中的血管紧张素转换酶2：朋友还是敌人？
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Jul 24;48(7):527-531. doi: 10.3760/cma.j.cn112148-20200303-00149.
9
[ACE2 and coronavirus - a question of balance and dynamics?].[血管紧张素转换酶2与冠状病毒——平衡与动态变化的问题？]
Lakartidningen. 2020 Apr 17;117:F3S3.
10
Is low sodium intake a risk factor for severe and fatal COVID-19 infection?低钠摄入是严重和致命的COVID-19感染的危险因素吗？
Eur J Intern Med. 2020 May;75:109. doi: 10.1016/j.ejim.2020.04.003. Epub 2020 Apr 8.
引用本文的文献
1
Metabolomics and lipidomics of plasma biomarkers for tuberculosis diagnostics using UHPLC-HRMS.使用超高效液相色谱-高分辨率质谱法对用于结核病诊断的血浆生物标志物进行代谢组学和脂质组学研究。
Front Cell Infect Microbiol. 2025 Jun 30;15:1526740. doi: 10.3389/fcimb.2025.1526740. eCollection 2025.
2
The relationship between chronic immune response and neurodegenerative damage in long COVID-19.长新冠中慢性免疫反应与神经退行性损伤的关系。
Front Immunol. 2022 Dec 16;13:1039427. doi: 10.3389/fimmu.2022.1039427. eCollection 2022.
3
Lower Serum Angiotensin-Converting Enzyme Level in Relation to Hyperinflammation and Impaired Antiviral Immune Response Contributes to Progression of COVID-19 Infection.血清血管紧张素转换酶水平降低与炎症反应过度及抗病毒免疫反应受损有关，这促使新冠病毒感染病情进展。
Infect Dis Ther. 2021 Dec;10(4):2431-2446. doi: 10.1007/s40121-021-00513-8. Epub 2021 Aug 13.
4
Role of the Renin-Angiotensin-Aldosterone and Kinin-Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID.肾素-血管紧张素-醛固酮系统和激肽-缓激肽系统在 COVID-19 和长新冠心血管并发症中的作用。
Int J Mol Sci. 2021 Jul 31;22(15):8255. doi: 10.3390/ijms22158255.
5
Effects of the Na/H Ion Exchanger on Susceptibility to COVID-19 and the Course of the Disease.钠/氢离子交换器对新型冠状病毒肺炎易感性及病程的影响。
J Renin Angiotensin Aldosterone Syst. 2021 Jun 15;2021:4754440. doi: 10.1155/2021/4754440. eCollection 2021.
6
Functional ACE2 deficiency leading to angiotensin imbalance in the pathophysiology of COVID-19.功能性 ACE2 缺乏导致 COVID-19 病理生理学中血管紧张素失衡。
Rev Endocr Metab Disord. 2022 Apr;23(2):151-170. doi: 10.1007/s11154-021-09663-z. Epub 2021 Jul 1.
本文引用的文献
1
Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine.血管疾病或心血管危险因素与 COVID-19 患者管理指南：来自血管外科学-欧洲独立血管学基金会/血管医学的立场文件。
Thromb Haemost. 2020 Dec;120(12):1597-1628. doi: 10.1055/s-0040-1715798. Epub 2020 Sep 13.
2
Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication.重组人血管紧张素转换酶2：新型冠状病毒感染及其并发症的潜在治疗方法
Acta Pharmacol Sin. 2020 Sep;41(9):1255-1257. doi: 10.1038/s41401-020-0430-6. Epub 2020 Jun 24.
3
Comment on "ACE inhibitors and COVID-19: We don't know yet".关于《血管紧张素转换酶抑制剂与2019冠状病毒病：我们尚不清楚》的评论
J Card Surg. 2020 Jun;35(6):1387. doi: 10.1111/jocs.14647.
4
Elevation of plasma angiotensin II level is a potential pathogenesis for the critically ill COVID-19 patients.血浆血管紧张素II水平升高是危重型新型冠状病毒肺炎患者的潜在发病机制。
Crit Care. 2020 Jun 5;24(1):290. doi: 10.1186/s13054-020-03015-0.
5
Estimation of Renin-Angiotensin-Aldosterone-System (RAAS)-Inhibitor effect on COVID-19 outcome: A Meta-analysis.评估肾素-血管紧张素-醛固酮系统（RAAS）抑制剂对 COVID-19 结局的影响：一项荟萃分析。
J Infect. 2020 Aug;81(2):276-281. doi: 10.1016/j.jinf.2020.05.052. Epub 2020 May 28.
6
Angiotensin II infusion in COVID-19-associated vasodilatory shock: a case series.血管紧张素 II 输注治疗新型冠状病毒肺炎相关血管舒张性休克：病例系列
Crit Care. 2020 May 15;24(1):227. doi: 10.1186/s13054-020-02928-0.
7
Comment on 'Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?'.关于《血管紧张素受体阻断药物在新冠疫情中是否可能有害？》的评论
J Hypertens. 2020 Jun;38(6):1189-1198. doi: 10.1097/HJH.0000000000002481.
8
Blockade of SARS-CoV-2 infection by recombinant soluble ACE2.重组可溶性血管紧张素转换酶2对严重急性呼吸综合征冠状病毒2感染的阻断作用
Kidney Int. 2020 Jun;97(6):1091-1093. doi: 10.1016/j.kint.2020.04.009. Epub 2020 Apr 14.
9
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.新冠病毒病患者中的肾素-血管紧张素-醛固酮系统抑制剂
N Engl J Med. 2020 Apr 23;382(17):1653-1659. doi: 10.1056/NEJMsr2005760. Epub 2020 Mar 30.
10
Angiotensin A/Alamandine/MrgD Axis: Another Clue to Understanding Cardiovascular Pathophysiology.血管紧张素A/阿兰曼丁/ MrgD轴：理解心血管病理生理学的另一条线索。
Int J Mol Sci. 2016 Jul 20;17(7):1098. doi: 10.3390/ijms17071098.
Zotero 插件